{"number":"US12697304B2","kindCode":"B2","documentType":"grant","title":{"original":"Solid dosage form production","english":"Solid dosage form production"},"abstract":{"original":"The present invention utilizes 3D printing technology, specifically fused filament fabrication (FFF) 3D printing, to produce solid dosage forms, such as pharmaceutical tablets. The production process utilizes novel printing filaments, typically on a spool, which contain the active ingredient. Such active-containing filaments have proved to be extremely robust and the principles outlined in the present disclosure provide access to a variety of viable formulations directly from a 3D printer. This, for the first time, affords a viable means for the in situ (e.g.…","english":"The present invention utilizes 3D printing technology, specifically fused filament fabrication (FFF) 3D printing, to produce solid dosage forms, such as pharmaceutical tablets. The production process utilizes novel printing filaments, typically on a spool, which contain the active ingredient. Such active-containing filaments have proved to be extremely robust and the principles outlined in the present disclosure provide access to a variety of viable formulations directly from a 3D printer. This, for the first time, affords a viable means for the in situ (e.g.…"},"applicants":["University of Lancashire"],"inventors":["Mohamed Albed Alhnan"],"filingDate":"2023-08-07","publicationDate":"2026-08-04","grantDate":"2026-08-04","verifiedWithOffice":true,"pdfUrl":"https://downloadpatent.com/pdf/US12697304B2.pdf","pages":{"en":"https://downloadpatent.com/patent/US12697304B2","zh-Hant":"https://downloadpatent.com/zh-Hant/patent/US12697304B2","ja":"https://downloadpatent.com/ja/patent/US12697304B2"}}